• Title/Summary/Keyword: DDBS-16

Search Result 2, Processing Time 0.017 seconds

Response Surface Modeling by Genetic Programming I: A Directional Derivative-Based Smoothering Method (유전적 프로그래밍을 이용한 응답면의 모델링 I : 방향도함수 기반의 Smoothering 기법)

  • Yeun, Yun-Seog;Rhee, Wook
    • Journal of Information Technology Application
    • /
    • v.3 no.3
    • /
    • pp.1-24
    • /
    • 2001
  • This paper introduces the genetic programming algorithm(GP), which can approximate highly nonlinear functions, as a tool for the modeling of response surfaces. When the response surfaces is approximated, the very small or minimal teaming set should be used, and thus it is almost certain that GP trees will show overfilling that must be avoided at all costs. We present a novel method, calledDDBS(DirectionalDerivative-Based Smoothering), which very effectively eliminates the unwanted behaviors of GP trees such as large peaks, oscillations, and also overfitting. Four illustrative numerical examples are given to demonstrate the performance of the genetic programming algorithm that adopts DDBS.

  • PDF

Three Months Subacute Toxicity of Water Soluble Dimethyl Dimethoxy Biphenylate Derivative in Rats (수용성 DDB 유도체의 3개월 반복투여독성에 관한 연구)

  • 신민기;손장원;김민영;방명주;김정현;최진혁;김준성;배미옥;문전옥
    • Toxicological Research
    • /
    • v.16 no.2
    • /
    • pp.151-161
    • /
    • 2000
  • The Three months subacute toxicity of water soluble dimethyl dimethoxy biphenylate derivative (DDB-S), newly formulated therapeutic agent for hepatitis, was invesgated in SD rats. The body weight and clinical signs were observed after intravenous injection of DDBs at doses of 57, 75 and 100 mg/kg/day for three months. Decrease in motor activity and tremor were observed above 75mg/kg treated groups. Statistically significant changes at serum biochemical analysis were found in some group, how-ever, those changes were within the normal range and had no relationship with dosage. There was no abnormal morphological and pathological findings in relation to DDB-S treatment. The no observable adverse effect level of DDB-S in rats was estimated to be 57 mg/kg/day in this study.

  • PDF